Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020)
Publication
, Journal Article
Sawitzki, B; Harden, PN; Reinke, P; Moreau, A; Hutchinson, JA; Game, DS; Tang, Q; Guinan, EC; Battaglia, M; Burlingham, WJ; Roberts, ISD ...
Published in: LANCET
2020
Duke Scholars
Published In
LANCET
EISSN
1474-547X
ISSN
0140-6736
Publication Date
2020
Volume
395
Issue
10242
Start / End Page
1972 / 1972
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sawitzki, B., Harden, P. N., Reinke, P., Moreau, A., Hutchinson, J. A., Game, D. S., … Geissler, E. K. (2020). Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020). LANCET, 395(10242), 1972–1972.
Sawitzki, Birgit, Paul N. Harden, Petra Reinke, Aurelie Moreau, James A. Hutchinson, David S. Game, Qizhi Tang, et al. “Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020).” LANCET 395, no. 10242 (2020): 1972–1972.
Sawitzki B, Harden PN, Reinke P, Moreau A, Hutchinson JA, Game DS, et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020). LANCET. 2020;395(10242):1972–1972.
Sawitzki, Birgit, et al. “Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020).” LANCET, vol. 395, no. 10242, 2020, pp. 1972–1972.
Sawitzki B, Harden PN, Reinke P, Moreau A, Hutchinson JA, Game DS, Tang Q, Guinan EC, Battaglia M, Burlingham WJ, Roberts ISD, Streitz M, Josien R, Boeger CA, Scotta C, Markmann JF, Hester JL, Juerchott K, Braudeau C, James B, Contreras-Ruiz L, van der Net JB, Bergler T, Caldara R, Petchey W, Edinger M, Dupas N, Kapinsky M, Mutzbauer I, Otto NM, Oellinger R, Hernandez-Fuentes MP, Issa F, Ahrens N, Meyenberg C, Karitzky S, Kunzendorf U, Knechtle SJ, Grinyo J, Morris PJ, Brent L, Bushell A, Turka LA, Bluestone JA, Lechler RI, Schlitt HJ, Schlickeiser S, Cuturi MC, Friend PJ, Miloud T, Scheffold A, Secchi A, Crisalli K, Kang S-M, Hilton R, Banas B, Blancho G, Volk H-D, Lombardi G, Wood KJ, Geissler EK. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020). LANCET. 2020;395(10242):1972–1972.
Published In
LANCET
EISSN
1474-547X
ISSN
0140-6736
Publication Date
2020
Volume
395
Issue
10242
Start / End Page
1972 / 1972
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences